TRIB: Trinity Biotech plc Company Profile & Statistics

Trinity Biotech plc Profile

About

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.

Info & Links

CEO

John Gillard

Headquarters

IDA BUSINESS PARK, BRAY
WICKLOW, L2 A98 H5C8, IRELAND

Auditor

GRANT THORNTON

Share holders

Employees

401

Trinity Biotech plc Statistics

Valuation Measures

Market Capitalization²

14.33M

Enterprise Value

130.19M

Enterprise Value/EBITDA(ttm)

-6.53

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

35.94%

Operating Margin(ttm)

-68.56%

Profit Margin(ttm)

-78.52%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-58.57%

Return on Assets(ttm)

-32.77%

Income Statement

Revenue(ttm)

48.57M

Revenue Per Share(ttm)

Gross Profit(ttm)

17.87M

EBITDA(ttm)³

-19.94M

Net Income Available to Common(ttm)

-36.85M

Diluted EPS(ttm)

-9.40

Share Statistics

Beta (5Y Monthly)

52-Week Change

-11.14%

S&P 500 52-Week Change

13.36%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

Float⁴

3.30M

% Held by Insiders

8.20%

% Held by Institutions

78.97%

Balance Sheet

Total Cash(mrq)

1.34M

Total Cash Per Share(mrq)

Total Debt(mrq)

117.20M

Total Debt/Equity(mrq)

-214.21%

Current Ratio(mrq)

1.03%

Quick Ratio(mrq)

0.47%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-4.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TRIB

Trinity Biotech plc